DJIA 17,131.97 100.83 0.59%
NASDAQ 4,552.76 33.86 0.75%
S&P 500 1,998.98 14.85 0.75%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

39.50 0.66 (1.70%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $39.50 1.70%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.64
Previous Close $38.84
Daily Range $38.20 - $39.66
52-Week Range $22.25 - $62.66
Market Cap $4.7B
P/E Ratio -47.95
Dividend (Yield) $0.00 (0.0%)
Volume 1,598,240
Average Daily Volume 2,053,485
Current FY EPS -$0.70





Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Isis Pharmaceuticals (ISIS) Weak On High Volume Today

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

October 31st Options Now Available For Isis Pharmaceuticals (ISIS)

'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics

Notable ETF Inflow Detected - IWM, ISIS, GPK, ULTI

Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog

3 Health Care Stocks Pushing The Sector Higher

See More ISIS News...

ISIS's Top Competitors

ISIS $39.50 (1.70%)
Current stock: ISIS
CELG $92.57 (3.48%)
Current stock: CELG
AMGN $139.33 (0.99%)
Current stock: AMGN
BIIB $326.88 (2.11%)
Current stock: BIIB